Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioblastoma × Dexamethasone × Clear all

Phase

Status

Withdrawn 2 Terminated 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 75 Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Recurrence 15 Neoplasms 10 Burkitt Lymphoma 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Immunoglobulin Light-chain Amyloidosis 7 Neoplasms, Plasma Cell 6 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5 Lung Neoplasms 5 Leukemia, Biphenotypic, Acute 5 Hodgkin Disease 5 Waldenstrom Macroglobulinemia 4 Leukemia 4 Carcinoma, Non-Small-Cell Lung 4 Triple Negative Breast Neoplasms 3 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Lymphoma, B-Cell 3 Lymphoma 3 Brain Neoplasms 3 Smoldering Multiple Myeloma 2 Renal Insufficiency 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Hematologic Neoplasms 2

Interventions

Temozolomide 40 Radiotherapy 18 Magnetic Resonance Spectroscopy 12 pembrolizumab 11 Specimen Handling 10 Lomustine 10 Bevacizumab 10 Radiation 7 Cyclophosphamide 5 fludarabine 4 Nivolumab 4 Aminolevulinic Acid 4 Transurethral Resection of Bladder 3 Surgical Procedures, Operative 3 Ipilimumab 3 regorafenib 2 olaparib 2 fluciclovine F-18 2 atezolizumab 2 antisecretory factor 2 abemaciclib 2 Standard of Care 2 Restraint, Physical 2 Re-Irradiation 2 Radiotherapy, Intensity-Modulated 2 Palliative Care 2 Oncolytic Virotherapy 2 ONC206 2 Metformin 2 Leukapheresis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04266977 2025-07-09

RESDEX

Insel Gruppe AG, University Hospital Bern

Phase NA Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡